Profile picture

Doctor Jan Johansson

Resverlogix Inc., San Francisco (United States of America)
Membership: ESC Professional Member
Follow
Logo ESC

Contributor content

Vascular and Alzheimer's disease effects by the apoE derived ABCA1 agonist CS6253
Presentation
Vascular and Alzheimer's disease effects by the apoE derived ABCA1 agonist CS6253
Read more
Lowering the neutrophil to lymphocyte ratio by the BET inhibitor, apabetalone: potential implications for cardiovascular events in high risk patients
Presentation
Lowering the neutrophil to lymphocyte ratio by the BET inhibitor, apabetalone: potential implications for cardiovascular events in high risk patients
Read more
Atherosclerosis reduction and improved glucose control the ABCA1 agonist CS6253. In vitro and in vivo mechanism of action studies
Presentation
Atherosclerosis reduction and improved glucose control the ABCA1 agonist CS6253. In vitro and in vivo mechanism of action studies
Read more

ESC 365 is supported by

novartis Explore sponsored resources